Veronika B. Felber

Walther Meißner Str. 3
Garching Bei Munchen, BY 85748, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Synthesis and in vitro evaluation of pharmacokinetically optimized 99mTc-labeled cholecystokinin-2 receptor-targeted peptides for improved SPECT imaging.

Synthesis and in vitro evaluation of pharmacokinetically optimized 99mTc-labeled cholecystokinin-2 receptor-targeted peptides for improved SPECT imaging.

Journal: EJNMMI radiopharmacy and chemistry

Published: May 20, 2026

Preclinical comparison of [111In]In-BPAMD and [99mTc]Tc-DPD for SPECT/CT-based bone imaging.

Preclinical comparison of [111In]In-BPAMD and [99mTc]Tc-DPD for SPECT/CT-based bone imaging.

Journal: Nuclear medicine and biology

Published: March 20, 2026

Towards Dual-Tracer SPECT for Prostate Cancer Imaging Using [99mTc]Tc-PSMA-I&S and [111In]In-RM2.

Towards Dual-Tracer SPECT for Prostate Cancer Imaging Using [99mTc]Tc-PSMA-I&S and [111In]In-RM2.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: April 27, 2025

CCK2 Receptor Ligand [68Ga]Ga-DOTA-CCK-66 PET/CT Outperforms [68Ga]Ga-DOTATOC PET/CT in a Patient with Small Cell Lung Cancer.

CCK2 Receptor Ligand [68Ga]Ga-DOTA-CCK-66 PET/CT Outperforms [68Ga]Ga-DOTATOC PET/CT in a Patient with Small Cell Lung Cancer.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: November 21, 2024

First-in-Human Serum Stability Studies of [177Lu]Lu-AMTG: A Step Toward Improved GRPR-Targeted Radiopharmaceutical Therapy.

First-in-Human Serum Stability Studies of [177Lu]Lu-AMTG: A Step Toward Improved GRPR-Targeted Radiopharmaceutical Therapy.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: November 11, 2024

Synthesis and Preclinical Evaluation of 177Lu-Labeled Radiohybrid PSMA Ligands for Endoradiotherapy of Prostate Cancer.

Synthesis and Preclinical Evaluation of 177Lu-Labeled Radiohybrid PSMA Ligands for Endoradiotherapy of Prostate Cancer.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: October 12, 2021

Substitution of l-Tryptophan by α-Methyl-l-Tryptophan in 177Lu-RM2 Results in 177Lu-AMTG, a High-Affinity Gastrin-Releasing Peptide Receptor Ligand with Improved In Vivo Stability.

Substitution of l-Tryptophan by α-Methyl-l-Tryptophan in 177Lu-RM2 Results in 177Lu-AMTG, a High-Affinity Gastrin-Releasing Peptide Receptor Ligand with Improved In Vivo Stability.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: October 04, 2021

Small peptide-based GLP-1R ligands: an approach to reduce the kidney uptake of radiolabeled GLP-1R-targeting agents?

Small peptide-based GLP-1R ligands: an approach to reduce the kidney uptake of radiolabeled GLP-1R-targeting agents?

Journal: EJNMMI radiopharmacy and chemistry

Published: April 04, 2021

Design of PSMA ligands with modifications at the inhibitor part: an approach to reduce the salivary gland uptake of radiolabeled PSMA inhibitors?

Design of PSMA ligands with modifications at the inhibitor part: an approach to reduce the salivary gland uptake of radiolabeled PSMA inhibitors?

Journal: EJNMMI radiopharmacy and chemistry

Published: September 28, 2020

Preclinical comparison of four [18F, natGa]rhPSMA-7 isomers: influence of the stereoconfiguration on pharmacokinetics.

Preclinical comparison of four [18F, natGa]rhPSMA-7 isomers: influence of the stereoconfiguration on pharmacokinetics.

Journal: EJNMMI research

Published: September 09, 2020

Showing 1-10 of 10

Last Updated: 09/26/2026